Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. - Wikidata - wikimedia - TriplyDB

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

http://www.wikidata.org/entity/Q39844102

about

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment Hepatitis C cirrhosis: New perspectives for diagnosis and treatment Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis AACR Cancer Progress Report 2014 Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Impact of an Electronic Medical Record-Based System to Promote Human Immunodeficiency Virus/Hepatitis C Virus Screening in Public Hospital Primary Care Clinics Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: a pilot project undertaken at the Vancouver General Hospital The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States Community-based HCV screening: knowledge and attitudes in a high risk urban population Chemopreventive strategies in hepatocellular carcinoma The changing burden of hepatitis C virus infection in the United States: model-based predictions."Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication Raising awareness of viral hepatitis: National Hepatitis Testing Day, May 19.Clinical impact of treatment timing for chronic hepatitis C infection: a decision model Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.Hepatitis C screening: getting it right.The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic.Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014 Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.Global control of hepatitis C: where challenge meets opportunity Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.Addicts with chronic hepatitis C: difficult to reach, manage or treat?Urban legends series: lichen planus.Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.Hepatitis C virus: a silent killer relevant to dentistry.Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity".Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.

P2860

Q26795559-60063B5A-8166-420B-9F19-95CDA94339F6 Q26799924-C51BF8C4-9916-434A-A6B4-C8F20F5498D4 Q26822903-4CC9D9DE-752A-43B9-83DE-CE0B8C97D1D9 Q27346723-3266EA43-1BCF-453A-8F22-353B68BD11DC Q30746254-E6A3CD96-DE2E-4018-AF69-6AC117549B20 Q33702754-65C62753-E0EE-4DDC-936F-E8F7146A642E Q33745336-62B32138-2F77-4BCD-9777-42DEE2D8BB57 Q33810973-AD2338C5-C39B-42D2-A96A-C2C3B89D4C4F Q33834958-87076FA4-1F5E-400A-B89F-31DF4C58FAA3 Q34484872-E950F860-666B-4928-A425-DEACAA1CF71D Q34491823-66C25B03-6E8C-47C3-AE09-D46371077386 Q34524584-CD24B10D-7178-4F29-96C3-0D2ABFBE0BCB Q34778712-00205970-4675-4EE6-9109-12F4B7005AFE Q35089934-7A3D4E54-A7B5-4B65-AEB9-822EC0118C11 Q35101365-2B6A106C-E4F2-49BC-8383-C55F1B236648 Q35168083-56E8682A-B8B3-4EBA-9986-D82A707DD257 Q35174428-62595184-24F0-49F9-90B4-11CCCFCF2ACF Q35641053-20E746D0-C24A-4290-AF8F-CA90387EF8AF Q35856819-7BC4E195-C2F4-48BA-AB52-8003FC3FBBA7 Q35889164-1F280722-B796-47D6-89E6-85724D20164D Q35985401-D476C1F2-9AD4-4D80-9304-9338ADAFDC36 Q36079851-5B632A78-0CAB-4B40-B273-C1F18D9C1E27 Q36138623-F2F9CC2E-9A68-4CE1-9C92-4B059D04A84C Q36340733-156458AA-FB76-40CF-9657-825685335BCA Q36575211-E300F17B-CD33-47BD-8E75-DC826B3D0805 Q36849533-03D448A8-F870-45C2-BF71-1D3BD358BB2B Q36858838-3A6AECC3-8E95-4E73-B900-414CF3A198CA Q36858890-1330A8F9-CC82-4CC8-8C2D-279805638EB6 Q36858898-4078994D-465D-49AA-B7E6-BF2D312CFFCB Q37052096-A98670BC-1AAC-49DA-A13D-BF890102DEBA Q37077112-80AF1E44-979D-4118-82C9-9E1DBA9311AB Q37158382-D8C767D7-8488-4E2F-B788-B97FCE760BFA Q37358632-5B14CA1E-0581-4958-A411-71AFAE7EABC0 Q38025689-2BE3B8AA-DCD1-4B72-A8B0-0E270B17F86B Q38064495-AD35ED8B-B5FB-4358-AB6F-0B0D493562A2 Q38165816-661019B5-839D-4D9C-A059-275FFF7EFB64 Q38199205-43D9C85D-668E-4663-AB92-2069A06EA529 Q38204468-69FC1CC4-4488-4E83-89AC-3A293E6897FF Q38264060-2AF99798-3976-470F-AA38-21B7215BF090 Q38380343-0BE60E52-DF9B-4C44-9CFF-0E86FEB8A7B4

P2860

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

http://www.wikidata.org/entity/Q39844102

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Forecasting the morbidity and ...... atitis C in the United States.

@en

Forecasting the morbidity and ...... atitis C in the United States.

@nl

type

label

Forecasting the morbidity and ...... atitis C in the United States.

@en

Forecasting the morbidity and ...... atitis C in the United States.

@nl

prefLabel

Forecasting the morbidity and ...... atitis C in the United States.

@en

Forecasting the morbidity and ...... atitis C in the United States.

@nl

P1433

Q39844102-E948E790-8825-469D-8608-33DFC00E6DDB

P1476

Q39844102-5FACEBC6-A7F3-416A-A97C-AA0203B4C2DF

P2093

Q39844102-3FFDF942-533D-4A94-9D58-E99D2F935305

Q39844102-5DB58FEB-0B4F-4C05-A6C9-570682BDFE5E

Q39844102-85471B8E-8FF7-48C1-8A4E-DE0CA5A1A67D

Q39844102-9373E66E-67A7-489D-B57F-15BA697EE311

Q39844102-9FCED893-1E8F-4927-9715-676C665412B3

Q39844102-F4480A6B-EC8A-44C3-93B0-57B8C40D083F

P304

Q39844102-7BECA204-06DB-49CA-9FF6-55E9B4A8B90C

P31

Q39844102-7C50AC73-FEB0-4B80-BCCD-81226AEC7698

P356

Q39844102-60F40103-4C00-4179-B89F-C5C255A454D5

P433

Q39844102-AC69E4E2-C9DF-4B94-ABAD-5CE5C093C1D3

P478

Q39844102-0CF8745E-A0C5-4C20-8DF5-EF8C668C2D8E

P577

Q39844102-CC0FECB9-2B8E-4471-A2C8-DF17054671FC

P5875

Q39844102-C9914FCB-0C63-4744-B735-472EA86A7904

P698

Q39844102-C901B968-38BB-4DCF-AB77-8F34BB088264

P921

Q39844102-5915C25D-48D5-4931-A50E-74B7BFF9113F

P356

J.DLD.2010.05.006

P1433

Digestive and Liver Disease

P1476

Forecasting the morbidity and ...... atitis C in the United States.

@en

P2093

Bryce D Smith

http://www.w3.org/2001/XMLSchema#string

Cindy M Weinbaum

http://www.w3.org/2001/XMLSchema#string

David B Rein

http://www.w3.org/2001/XMLSchema#string

John S Wittenborn

http://www.w3.org/2001/XMLSchema#string

Miriam Sabin

http://www.w3.org/2001/XMLSchema#string

Sarah B Lesesne

http://www.w3.org/2001/XMLSchema#string

P304

66-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DLD.2010.05.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45951526

http://www.w3.org/2001/XMLSchema#string

P698

20739252

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis